Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Chronic Renal Failure

  Free Subscription

Articles published in Nephron

Retrieve available abstracts of 29 articles:
HTML format

Single Articles

    October 2022
  1. SENZAKI D, Yoshioka N, Nagakawa O, Inayama E, et al
    Modeling Low Muscle Mass Screening in Hemodialysis Patients.
    Nephron. 2022 Oct 21:1-9. doi: 10.1159/000526866.
    PubMed     Abstract available

    September 2022
  2. OZTURK S, Gursu M, Arici M, Sahin I, et al
    Evaluation of Outcomes of Peritoneal Dialysis Patients in the Post-COVID-19 Period: A National Multicenter Case-Control Study from Turkey.
    Nephron. 2022 Sep 30:1-9. doi: 10.1159/000526234.
    PubMed     Abstract available

  3. KIMURA H, Yoshida S, Takeuchi M, Kawakami K, et al
    Impact of Potentially Inappropriate Medications on Kidney Function in Chronic Kidney Disease: Retrospective Cohort Study.
    Nephron. 2022 Sep 16:1-8. doi: 10.1159/000526326.
    PubMed     Abstract available

    July 2022
  4. AGUR T, Zingerman B, Ben-Dor N, Alkeesh W, et al
    Humoral Response to the Third Dose of BNT162b2 COVID-19 Vaccine among Hemodialysis Patients.
    Nephron. 2022 Jul 27:1-8. doi: 10.1159/000525519.
    PubMed     Abstract available

  5. CHARITAKI E, Damianakis N, Garbidaki A, Stamataki E, et al
    DPP4 Inhibitor-Induced Bullous Pemphigoid in Patients with Diabetes and Chronic Kidney Disease: Clinical Case Series.
    Nephron. 2022 Jul 18:1-6. doi: 10.1159/000525520.
    PubMed     Abstract available

  6. BOMHOLT T, Kofod D, Norgaard K, Rossing P, et al
    Can the Use of Continuous Glucose Monitoring Improve Glycemic Control in Patients with Type 1 and 2 Diabetes Receiving Dialysis?
    Nephron. 2022 Jul 13:1-6. doi: 10.1159/000525676.
    PubMed     Abstract available

    May 2022
  7. MURT A, Dinc HO, Altiparmak MR, Yalin SF, et al
    Waning of SARS-CoV-2 Vaccine-Induced Immune Response over 6 Months in Peritoneal Dialysis Patients and the Role of a Booster Dose in Maintaining Seropositivity.
    Nephron. 2022 May 20:1-5. doi: 10.1159/000524658.
    PubMed     Abstract available

    April 2022
  8. GUINAULT D, Bernier M, Delarche A, Neuville S, et al
    Immunogenicity of the BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis Is Associated with Medical Conditions.
    Nephron. 2022 Apr 27:1-6. doi: 10.1159/000524292.
    PubMed     Abstract available

  9. ASH SR, Batlle D, Kendrick J, Oluwatosin Y, et al
    Effect of Sodium Zirconium Cyclosilicate on Serum Potassium and Bicarbonate in Patients with Hyperkalemia and Metabolic Acidosis Associated with Chronic Kidney Disease: Rationale and Design of the NEUTRALIZE Study.
    Nephron. 2022 Apr 22:1-11. doi: 10.1159/000523911.
    PubMed     Abstract available

    March 2022
  10. KONN V, Motrapu M, Swiderska MK, Anders HJ, et al
    Drug Testing for Chronic Kidney Disease and Diabetes in Animals versus Humans: A Comparative Analysis of Study Designs and Reporting Qualities.
    Nephron. 2022 Mar 23:1-11. doi: 10.1159/000523666.
    PubMed     Abstract available

    February 2022
  11. TODA A, Hara S, Tsuji H, Arase Y, et al
    Effects of Body Weight Change on Development of Chronic Kidney Disease in Obese Metabolic Phenotypes.
    Nephron. 2022 Feb 18:1-8. doi: 10.1159/000522159.
    PubMed     Abstract available

  12. HAKAMAKI M, Jarvisalo MJ, Lankinen R, Koivuviita N, et al
    Evolution of Quality of Life in Chronic Kidney Disease Stage 4-5 Patients Transitioning to Dialysis and Transplantation.
    Nephron. 2022 Feb 9:1-10. doi: 10.1159/000521771.
    PubMed     Abstract available

  13. SY J, Wenziger C, Marroquin M, Kalantar-Zadeh K, et al
    Warfarin Use, Stroke, and Bleeding Risk among Pre-Existing Atrial Fibrillation US Veterans Transitioning to Dialysis.
    Nephron. 2022 Feb 4:1-9. doi: 10.1159/000521494.
    PubMed     Abstract available

    January 2022
  14. KIDA N, Morishima T, Tsubakihara Y, Miyashiro I, et al
    Stage at Diagnosis and Prognosis of Colorectal, Stomach, Lung, Liver, Kidney, and Bladder Cancers in Dialysis Patients: A Multicenter Retrospective Study Using Cancer Registry Data and Administrative Data.
    Nephron. 2022 Jan 28:1-10. doi: 10.1159/000521603.
    PubMed     Abstract available

  15. LEI Q, Xu F, Liang S, Liang D, et al
    Clinical Acute Kidney Injury and Histologic Acute Tubular-Interstitial Injury and Their Prognosis in Diabetic Nephropathy.
    Nephron. 2022;146:351-359.
    PubMed     Abstract available

  16. JUNG J, Lee JH, Park YS
    Therapeutic Response and Long-Term Renal Outcomes in Childhood Idiopathic Steroid-Resistant Nephrotic Syndrome: A Single-Center Study.
    Nephron. 2022;146:327-334.
    PubMed     Abstract available

  17. SOOHOO M, Hashemi L, Hsiung JT, Moradi H, et al
    Association of Serum Triglycerides and Renal Outcomes among 1.6 Million US Veterans.
    Nephron. 2022;146:457-468.
    PubMed     Abstract available

    December 2021
  18. OUYANG J, Bajracharya S, John S, Wagner J, et al
    Clotting of Hemodialysis Access in Patients with COVID-19 in an Inner-City Hospital.
    Nephron. 2021 Dec 20:1-6. doi: 10.1159/000520174.
    PubMed     Abstract available

    November 2021
  19. PETNAK T, Thongprayoon C, Cheungpasitporn W, Shawwa K, et al
    The Prognostic Importance of Serum Sodium for Mortality among Critically Ill Patients Requiring Continuous Renal Replacement Therapy.
    Nephron. 2021 Nov 18:1-7. doi: 10.1159/000519686.
    PubMed     Abstract available

  20. DONG X, Cao R, Li Q, Yin L, et al
    The Long Noncoding RNA-H19 Mediates the Progression of Fibrosis from Acute Kidney Injury to Chronic Kidney Disease by Regulating the miR-196a/Wnt/beta-Catenin Signaling.
    Nephron. 2021 Nov 17:1-11. doi: 10.1159/000518756.
    PubMed     Abstract available

  21. BOMHOLT T, Feldt-Rasmussen B, Butt R, Borg R, et al
    Hemoglobin A1c and Fructosamine Evaluated in Patients with Type 2 Diabetes Receiving Peritoneal Dialysis Using Long-Term Continuous Glucose Monitoring.
    Nephron. 2021 Nov 3:1-7. doi: 10.1159/000519493.
    PubMed     Abstract available

    October 2021
  22. BROGAN M, Ross MJ
    The Impact of Chronic Kidney Disease on Outcomes of Patients with COVID-19 Admitted to the Intensive Care Unit.
    Nephron. 2021 Oct 11:1-5. doi: 10.1159/000519530.
    PubMed     Abstract available

    January 2021
  23. HAKAMAKI M, Hellman T, Lankinen R, Koivuviita N, et al
    Elevated Troponin T and Enlarged Left Atrium Are Associated with the Incidence of Atrial Fibrillation in Patients with CKD Stage 4-5.
    Nephron. 2021;145:71-77.
    PubMed     Abstract available

  24. DE VRIES BCS, Berger SP, Bakker SJL, de Borst MH, et al
    Pre-Transplant Plasma Potassium as a Potential Risk Factor for the Need of Early Hyperkalaemia Treatment after Kidney Transplantation: A Cohort Study.
    Nephron. 2021;145:63-70.
    PubMed     Abstract available

  25. MORALES E, Galindo M, Trujillo H, Praga M, et al
    Update on Lupus Nephritis: Looking for a New Vision.
    Nephron. 2021;145:1-13.
    PubMed     Abstract available

  26. MASAJTIS-ZAGAJEWSKA A, Pawlowicz E, Nowicki M
    Effect of Short-Term Cold Exposure on Central Aortic Blood Pressure in Patients with CKD.
    Nephron. 2021;145:20-26.
    PubMed     Abstract available

  27. MOHAMMED A, Marie MA, Abdulazim DO, Hassan M, et al
    Serum Urate Lowering Therapy Using Allopurinol Improves Serum 25 Hydroxy Vitamin D in Stage 3-5 CKD Patients: A Pilot Study.
    Nephron. 2021;145:133-136.
    PubMed     Abstract available

  28. KAIMORI JY, Mori T, Namba-Hamano T, Morimoto T, et al
    Cyclosporine A Treatment of Proteinuria in a New Case of MAFB-Associated Glomerulopathy without Extrarenal Involvement: A Case Report.
    Nephron. 2021;145:445-450.
    PubMed     Abstract available

  29. KALANTAR-ZADEH K, Li PK, Tantisattamo E, Kumaraswami L, et al
    Living Well with Kidney Disease by Patient and Care-Partner Empowerment: Kidney Health for Everyone Everywhere.
    Nephron. 2021;145:205-211.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.